Maintaining and strengthening pharmaceutical manufacturing within the European Union should be a strategic priority, Greek health minister Adonis Georgiadis … The concept of ‘Made in Europe’ must be clearly defined to include all key production steps: active pharmaceutical ingredients (APIs), essential starting materials, and finished dosage form (FDF) manufacturing, he said. Georgiadis underlined that a definition focused solely on the API is unacceptable.
…
The Greek health minister said resilience as a procurement criterion is crucial. However, he pointed out that it must be accompanied by mandatory multi-supplier contracting in tenders, as it is essential for supporting domestic production, diversifying supply sources for critical medicines, and controlling public expenditure.
…
He is absolutely not wrong.